Cellular adaptive immune system plays a crucial role in trastuzumab clinical efficacy

J Clin Oncol. 2010 Jul 20;28(21):e369-70; author reply e371. doi: 10.1200/JCO.2010.28.6922. Epub 2010 May 17.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / immunology
  • Female
  • Humans
  • Receptor, ErbB-2 / analysis
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab